Keya Pitts Mph

Head, Global Safety Operations at Nestlé Health Science

Keya Pitts MPH has extensive work experience in the healthcare and pharmaceutical industry. Keya currently holds the position of Head, Global Safety Operations at Nestlé Health Science. Prior to this, they worked at Alnylam Pharmaceuticals as Vice President, Global Safety Operations, where they were responsible for leading all operational aspects of the Global Patient Safety and Risk Management Expertise Area. Keya also served as the Head of Quality, Standards, and Compliance at Alnylam Pharmaceuticals.

Before joining Alnylam Pharmaceuticals, Keya Pitts worked at Astellas Pharma as Executive Director, Clinical and Pharmacovigilance Quality Assurance and Global Head of PVQA. Keya was responsible for managing pharmacovigilance staff, processes, systems, and resources globally. Keya also held the position of Senior Director, Pharmacovigilance Quality Assurance and Global Head for PVQA at Astellas Pharma.

Keya Pitts also gained experience at Otsuka Pharmaceutical Companies (U.S.) as Director, Quality Control GCP R&D, where they were responsible for driving quality control throughout the clinical development and commercialization lifecycle. Keya also served as the Global Head, Pharmacovigilance Compliance and Business Management, Director, Global PV at Otsuka Pharmaceutical Companies (U.S.).

Earlier in their career, Keya Pitts worked at Purdue Pharma as Director of Drug Safety Operations and Associate Director of Drug Safety Pharmacovigilance. Keya also worked at Bristol-Myers Squibb as a Regulatory Affairs Manager, Drug Safety, and at AstraZeneca Pharmaceuticals as a Drug Safety Scientist and Epidemiology Associate/Dictionary Manager.

In summary, Keya Pitts MPH has held various leadership roles in global safety operations, quality assurance, and pharmacovigilance in the healthcare and pharmaceutical industry.

Keya Pitts holds a Master of Public Health (MPH) degree in Epidemiology from The Johns Hopkins University - Bloomberg School of Public Health. Keya also completed their Bachelor of Arts (BA) degree in General Science from Cheyney University of Pennsylvania. Additionally, Keya pursued coursework in Biomedical Sciences with a focus on Neuropharmacology at the University of Pennsylvania School of Medicine.

Links

Previous companies

Alnylam Pharmaceuticals logo
Bristol-Myers Squibb logo
Purdue Pharma logo
Otsuka Pharmaceutical US logo
AstraZeneca logo

Timeline

  • Head, Global Safety Operations

    March, 2023 - present